Design of nuclease resistant protein kinase cα DNA enzymes with potential therapeutic application
- 25 February 2000
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 296 (3) , 937-947
- https://doi.org/10.1006/jmbi.2000.3491
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Imaging Protein Kinase Cα Activation in CellsScience, 1999
- A nuclease-resistant protein kinase Cα ribozyme blocks glioma cell growthNature Biotechnology, 1998
- Loss of protein kinase C function induces an apoptotic responseOncogene, 1998
- Translating genomics information into therapeutics: A key role for oligonucleotidesNature Biotechnology, 1997
- BCL-2 antisense therapy in patients with non-Hodgkin lymphomaThe Lancet, 1997
- A Minimised Hammerhead Ribozyme with Activity against Interleukin-2 in Human CellsBiochemical and Biophysical Research Communications, 1997
- Protein kinase C: a worthwhile target for anticancer drugs?Anti-Cancer Drugs, 1997
- Chemical Modification of Hammerhead RibozymesJournal of Biological Chemistry, 1995
- Thermodynamic Parameters To Predict Stability of RNA/DNA Hybrid DuplexesBiochemistry, 1995
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992